New brain scan method could reveal how Parkinson's progresses

NCT ID NCT05516719

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses special brain scans (PET, SPECT, and MRI) to look for a marker that shows how Parkinson's disease changes over time. Researchers will scan 44 people with Parkinson's to see if a compound called BU99008 can highlight brain cell activity linked to the disease. The goal is to find a better way to measure disease progression, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BU99008 tracer (for PET scan)
What this could lead to
If successful, this could identify a new way to track Parkinson's disease progression using brain scans, helping future research.
What could go wrong
This is a small, early-stage observational study. It is not testing a treatment, so there is no direct benefit to participants. The findings may not lead to a practical test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURODEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Of Exeter

    RECRUITING

    Exeter, Devon, EX1 2LU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.